Australia's largest stock trading and investment forum Australia's #1 stock forum

GMV

Click for more information

0.00%

3.9¢ g medical innovations holdings limited

Ann: Australia Biotech Invest 2017 Presentation, page-107

First 107 Last

Share
Profile

Follow
uncle_elmer

701 Posts.

97

18/12/17

19:28

Post #: 29718365
Share

Originally posted by $tockfella ↑

Just revisiting this announcement. CFDA is expected in the first half of Financial Year 2018. That means before January. If it is delayed slightly, worst case suggests it will be in January. Curious to know when the case starts being exported to approved territories and countries. American, Europe, Australia and NZ. Perhaps impatient holders were expecting some sales by now and also CFDA to be approved by now?

Expand

Pretty sure GMV Financial Year (FY) runs Jan- Dec (refer to last quarterly), so means any time before June 2018...happy to be corrected.

GMV Price at posting: 35.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

First 107 Last

Add GMV (ASX) to my watchlist